Search

everythinglearnresearchcommunity

for

Search:↓

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

17-β-Estradiol applied to the skin stops hair growth, while ICI 182 780 helps hair grow in mice.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Different skin cells process testosterone differently, and certain drugs can change this process, possibly helping treat acne and hair loss.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Hormone levels in hair change during pregnancy, with progesterone increasing significantly compared to non-pregnant women.

Finasteride safely lowers DHT levels without affecting hormone levels, helping with conditions like enlarged prostate, acne, and hair loss.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

150 kHz electromagnetic radiation might help improve PCOS in rats.

Adjusting estradiol-ANGPT2 levels can promote hair growth in female pattern hair loss.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Estradiol may protect ear cells from hearing loss caused by a chemotherapy drug by activating a protective pathway.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Hair can reliably measure average estradiol levels over months in humans and monkeys.

A lotion with minoxidil, hydrocortisone butyrate, and 17a-estradiol can improve or stabilize Frontal Fibrosing Alopecia in some cases, but there's no universally-accepted treatment yet.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.